Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) COO Patrick O’brien Sells 22,841 Shares
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) COO Patrick O’brien sold 22,841 shares of the business’s stock in a transaction on Friday, January 5th. The stock was sold at an average price of $35.27, for a total transaction of $805,602.07. Following the completion of the transaction, the chief operating officer now owns 464,385 shares […]
More Stories
Enservco (NYSE:ENSV) Receives New Coverage from Analysts at StockNews.com
StockNews.com began coverage on shares of Enservco (NYSE:ENSV – Free Report) in a research note issued to investors on Saturday....
Bicara Therapeutics Inc.’s Quiet Period To End on October 23rd (NASDAQ:BCAX)
Bicara Therapeutics’ (NASDAQ:BCAX – Get Free Report) quiet period is set to end on Wednesday, October 23rd. Bicara Therapeutics had...
RingCentral (NYSE:RNG) Cut to “Buy” at StockNews.com
StockNews.com downgraded shares of RingCentral (NYSE:RNG – Free Report) from a strong-buy rating to a buy rating in a report...
Tri Pointe Homes (TPH) to Release Quarterly Earnings on Thursday
Tri Pointe Homes (NYSE:TPH – Get Free Report) will be posting its quarterly earnings results before the market opens on...
iRobot (NASDAQ:IRBT) Upgraded at StockNews.com
StockNews.com upgraded shares of iRobot (NASDAQ:IRBT – Free Report) from a sell rating to a hold rating in a research...
VeriSign (VRSN) Set to Announce Quarterly Earnings on Thursday
VeriSign (NASDAQ:VRSN – Get Free Report) is set to post its quarterly earnings results after the market closes on Thursday,...